Year: 2017
Type: editorial
Abstract: Dr. Pool in his commentary (1) responding to the practice recommendations for Sperm DNA Fragmentation (SDF) testing based on clinical scenarios by Agarwal et al. (2) critically appraised the applicability of such testing to couples embarking in Assisted Reproductive Technology (ART).
Institutions: Androfert, Hamad Medical Corporation, Cleveland Clinic
Language: English
Subfield: Statistics, Probability and Uncertainty
Field: Decision Sciences
Domain: Social Sciences
Open Access status: hybrid
OpenAlex ID: W2605119538
